Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788943 · ClinicalTrials.gov registry record
Nicotine Receptor Levels and Smoking Cessation
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 24
- Enrollment target
NCT01788943: Completed study, sponsored by University of Pennsylvania.
NCT01788943 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788943 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The investigators propose to use positron emission tomography (PET) imaging to determine whether nicotinic receptor availability at pretreatment predicts smoking cessation success. The investigators will recruit 30 smokers from those enrolled in the Pharmacogenetics of Nicotine Addiction Treatment clinical trial. The investigators will measure nicotinic receptor availability using the PET radioligand 2-\[18F\]FA, after overnight abstinence and prior to initiation of treatment.
Primary Outcome
Acetylcholinergic Nicotine Receptor availability in the thalamus is decreased in smokers with slower rates of nicotine metabolism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-07 |
What the finished NCT01788943 record still lists
NCT01788943 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01788943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01788943 about?
NCT01788943 is a clinical study titled "Nicotine Receptor Levels and Smoking Cessation". The investigators propose to use positron emission tomography (PET) imaging to determine whether nicotinic receptor availability at pretreatment predicts smoking cessation success. The investigators will recruit 30 smokers from those enrolled in the Pharmacogenetics of Nicotine Addiction Treatment c...
What is the current status of trial NCT01788943?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-02. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT01788943?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia